Evolution of dissolved organic nitrogen (DON) during sludge reject water treatment revealed by FTICR-MS.

This study evaluated the ability to remove dissolved organic matter (DOM), particularly dissolved organic nitrogen (DON), at a molecular level using Fourier transform ion cyclotron resonance mass spectrometry (FTICR-MS) in a full-scale reject water treatment project comprising three steps of short-cut nitrification and denitrification, two-stage AO, and ultrafiltration membrane system. The results indicated that short-cut nitrification and denitrification were effective in reducing the DON concentration from an average of about 180 mg/L to 43 mg/L. The average molecular weight of DOM showed a decreasing trend from 238 Da to 160 Da. The percentage of nitrogen-containing organic compounds (CHON-DOM), which is the primary component of reject water DOM, increased from 65.79 % to 72.35 %, while the percentage of CHO-DOM decreased from 20.67 % to 15.24 %. The percentage of CHOS-DOM remained stable at 12.21 %-13.54 %. The percentage of protein-DOM decreased from 50.32 % to 18.40 %, while lignin-DOM increased from 36.16 % to 55.88 % and carbohydrate-DOM increased from 2.68 % to 9.74 %. The short-cut nitrification and denitrification and ultrafiltration membrane system both generated more unsaturated, highly aromatic DOM. This study provides insights into the effects of different wastewater treatment processes on the evolution of DOM/DON, which can be useful for effective DON control.

Enhanced sludge settlement of two stage PN/Anammox for reject water treatment with respective diatomite addition.

The present study investigated the potential of diatomite addition in enhancing sludge settlement of two-stage PN/Anammox for real reject water treatment, with a focus on sludge settling velocity, nitrogen removal capacity, sludge morphological features, and microbial community changes. The study found that diatomite addition significantly improved the sludge settleability of the two-stage PN/A process, resulting in a decrease in sludge volume index (SVI) from 70 to 80 mL/g to about 20-30 mL/g for both PN and Anammox sludge, although the sludge-diatomite interaction differed between the two types of sludge. In the PN sludge, diatomite acted as a carrier, while in the Anammox sludge, it acted as micro-nuclei. The addition of diatomite also increased the biomass amounts in the PN reactor, with a 5-29 % improvement attributed to its role as a biofilm carrier. The effects of diatomite addition on sludge settleability were more prominent at high mixed liquor suspended solids (MLSS), where sludge characteristics were deteriorated. Furthermore, the settling rate of the experimental group consistently exceeded that of the blank group after diatomite addition, with a significant decrease in SV. The relative abundance of Anammox bacteria was improved, and sludge particle size decreased in the diatomite-added Anammox reactor. Diatomite was effectively retained in both reactors, with less loss observed for Anammox than PN due to its more tightly wrapped structure, resulting in a stronger sludge-diatomite interaction. Overall, the results of this study suggest that diatomite addition has potential in enhancing the settling properties and performance of two-stage PN/Anammox for real reject water treatment.

AF-SSD: An Accurate and Fast Single Shot Detector for High Spatial Remote Sensing Imagery.

There are a large number of studies on geospatial object detection. However, many existing methods only focus on either accuracy or speed. Methods with both fast speed and high accuracy are of great importance in some scenes, like search and rescue, and military information acquisition. In remote sensing images, there are some targets that are small and have few textures and low contrast compared with the background, which impose challenges on object detection. In this paper, we propose an accurate and fast single shot detector (AF-SSD) for high spatial remote sensing imagery to solve these problems. Firstly, we design a lightweight backbone to reduce the number of trainable parameters of the network. In this lightweight backbone, we also use some wide and deep convolutional blocks to extract more semantic information and keep the high detection precision. Secondly, a novel encoding-decoding module is employed to detect small targets accurately. With up-sampling and summation operations, the encoding-decoding module can add strong high-level semantic information to low-level features. Thirdly, we design a cascade structure with spatial and channel attention modules for targets with low contrast (named low-contrast targets) and few textures (named few-texture targets). The spatial attention module can extract long-range features for few-texture targets. By weighting each channel of a feature map, the channel attention module can guide the network to concentrate on easily identifiable features for low-contrast and few-texture targets. The experimental results on the NWPU VHR-10 dataset show that our proposed AF-SSD achieves superior detection performance: parameters 5.7 M, mAP 88.7%, and 0.035 s per image on average on an NVIDIA GTX-1080Ti GPU.

lncRNA VIM­AS1 promotes cell proliferation, metastasis and epithelial­mesenchymal transition by activating the Wnt/ß­catenin pathway in gastric cancer.

The present study aimed to explore the biological functions and molecular mechanisms of the long non­coding RNA VIM antisense RNA 1 (VIM­AS1) in gastric cancer (GC). The expression of VIM­AS1 was analyzed in tissues from patients with GC and GC cell lines by reverse transcription­quantitative (RT­q)PCR. The relationship between VIM­AS1 expression and overall survival time of patients with GC was also assessed. To determine the biological functions of VIM­AS1, Cell Counting Kit­8 assay, colony formation assay, flow cytometry, wound healing assay and Transwell assay were employed. The targeting relationship among VIM­AS1, microRNA (miR)­8052 and frizzled 1 (FZD1) was verified by the dual luciferase reporter gene assay. The underlying molecular mechanism of VIM­AS1 on GC was determined by RT­qPCR and western blotting. In addition, tumor formation was detected in nude mice. The results of the present study demonstrated that VIM­AS1 was highly expressed in GC tissues and cells. In addition, VIM­AS1 expression was demonstrated to be closely related to the prognosis of patients with GC. Notably, silencing VIM­AS1 inhibited the proliferation, migration and invasion, and enhanced apoptosis of AGS and HGC­27 cells. Silencing VIM­AS1 significantly increased the protein expression levels of cleaved caspase­3, Bax and E­cadherin, but decreased the protein expression levels of Bcl­2, N­cadherin, vimentin, matrix metalloproteinase (MMP)­2, MMP­9, ß­catenin, cyclin D1, C­myc and FZD1. Additionally, silencing VIM­AS1 inhibited tumor growth in nude mice. Cumulatively, the present study demonstrated that VIM­AS1 may promote cell proliferation, migration, invasion and epithelial­mesenchymal transition by regulating FDZ1 and activating the Wnt/ß­catenin pathway in GC.

[Significance of peripheral perfusion index in early diagnosis and goal-directed therapy of septic shock patients: a prospective single-blind randomized controlled trial].

OBJECTIVE: To investigate the application of peripheral perfusion index (PPI) in early diagnosis and goal-directed therapy of septic shock, and to provide reference for the early clinical diagnosis and treatment of septic shock. METHODS: A prospective single-blind randomized controlled trial (RCT) was conducted. Adult patients with sepsis admitted to emergency medical department and intensive care unit (ICU) of the First People's Hospital of Lianyungang City in Jiangsu Province from January 2013 to December 2016 were enrolled. The patients were randomly divided into two groups (n = 46). The PPI group was defined using PPI < 1.4 as diagnosis of septic shock standard, and PPI > 2 as treatment guide target. Control group was defined according to the traditional diagnostic criteria of shock which systolic blood pressure was less than 90 mmHg (1 mmHg = 0.133 kPa) or systolic blood pressure value decrease > 40 mmHg baseline and bundle treatment was performed. The volume of fluid resuscitation, organ dysfunction, the sequential organ failure score (SOFA), acute physiology and chronic health evaluation II (APACHE II) score, continuous renal replacement therapy (CRRT) time, mechanical ventilation (MV) time, the length of ICU stay and 28-day mortality were observed. RESULTS: There were 39 and 27 septic shock patients in PPI group and control group respectively. The diagnostic criteria of traditional septic shock with blood pressure as "gold standard", the sensitivity of PPI < 1.4 for septic shock was 94.3%, the specificity was 28.2%, the authenticity was 66.3%, the positive predictive value was 64.1%, the negative predictive value was 78.6%, the positive likelihood ratio was 1.31, the negative likelihood ratio was 0.18. The per capita fluid replacement within 24 hours in the PPI group was significantly higher than that in the control group (mL: 4 601±1 250 vs. 3 458±1 006, P < 0.01), but there was no significant difference in the per capita volume of the patients diagnosed as septic shock (mL: 4 596±1 320 vs. 4 205±1 058, P > 0.05). Compared with the control group, the PPI group treated patients within 48 hours with less vascular active drugs (cases: 6 vs. 15), APACHE II and SOFA score were lower (48 hours: APACHE II was 10.2±2.1 vs. 12.0±3.2; 72 hours: SOFA was 5.1±1.8 vs. 6.0±2.1, APACHE II was 8.9±1.8 vs. 9.8±2.2), the period of CRRT and the length of ICU stay were shorter [the period of CRRT (days): 3.0±0.9 vs. 3.6±1.4, the length of ICU stay (days): 5.2±2.1 vs. 6.3±2.9), the difference was statistically significant (all P < 0.05). There was no significant difference in the liver and kidney function index, arterial blood lactic acid (Lac), MV time (days: 3.3±1.4 vs. 3.5±1.2) and 28-day mortality (15.22% vs. 19.57%) between two groups (all P > 0.05). CONCLUSIONS: The inadequacy of microcirculatory perfusion by oximetry-derived PPI is more sensitive to the diagnosis of septic shock than hypotension of systemic circulation. With PPI guiding the fluid resuscitation of septic shock patients, vasopressors can be withdrawn earlier and the duration of the CRRT and ICU can be decreased.

Chemokine (C­C motif) ligand 21/C­C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial­mesenchymal transition via the extracellular signal­regulated kinase signaling pathway.

C-C chemokine receptor type 7 (CCR7) has been implicated in lymph node metastasis of various cancers. Previous studies have revealed that epithelial­mesenchymal transition (EMT) is involved in the chemotactic process mediated by CCR7 and its ligands in various types of carcinoma. However, the underlying mechanism of this process remains to be fully elucidated. The present study investigated whether chemokine (C­C motif) ligand 21 (CCL21)/CCR7 may activate EMT of lung cancer cells and their associated signaling pathways. A549 and H520 lung cancer cell lines were examined in vitro in the present study. The results indicated that A549 and H520 expressed CCR7, but reduced levels of CCL21. Following stimulation of lung cancer cell lines with CCL21, the expression of the epithelial marker E­cadherin was downregulated, and the mesenchymal markers Vimentin/Slug and extracellular signal­regulated kinase (ERK) were upregulated. In addition, the ERK inhibitor PD98059 may inhibit EMT caused by CCL21, and decreased cell migration and invasion initiated by CCL21. Furthermore, lung adenocarcinoma tissues from 50 patients who underwent lung cancer operations were investigated by immunohistochemistry. The findings revealed that CCR7, Slug and Vimentin were highly expressed in lung carcinoma tissues, and were significantly associated with lymph node metastasis and clinical pathological stages, respectively. CCR7 expression was correlated positively with expression levels of Slug and Vimentin. CCL21 was expressed positively in the endothelium of lymphatic vessels adjacent to cancer cells, and weakly in lung cancer cells. Collectively, these results demonstrated that CCL21/CCR7 may activate EMT in lung cancer cells via the ERK1/2 signaling pathway. The current study provides evidence that a close interaction exists between CCL21/CCR7chemotaxis and EMT procedures in lung cancer metastasis, providing a basis for the development of therapeutic targets.

Efficacy and safety of proprotein convertase subtilisin/kexin type 9 monoclonal antibody in adults with familial hypercholesterolemia.

Proprotein convertase-subtilisin/kexin type 9 (PCSK9) monoclonal antibody is a new therapy to reduce low-density lipoprotein cholesterol (LDL-C) level in patients with familial hypercholesterolemia (FH). This pooled analysis aimed to estimate the efficacy and safety of PCSK9 antibody therapy in FH. Reports of randomized controlled trials (RCTs) comparing PCSK9 antibody to placebo were retrieved by a search of MEDLINE via PubMed, EMBASE, the Cochrane Library databases, ClinicalTrials.gov and Clinical Trial Results (up to November 30, 2015) with no language restriction. Data were abstracted by a standardized protocol. We found eight RCTs (1,879 patients with FH) for the pooled analysis. As compared with placebo, PCSK9 antibody therapy remarkably reduced LDL-C level (mean reduction: -48.54 %, 95 % CI: -53.19 to -43.88), total cholesterol (mean reduction: -31.08%, 95 % CI: -35.20 to -26.95), lipoprotein (a) (mean reduction: -20.44%, 95 % CI: -25.21 to -15.66), and apolipoprotein B (mean reduction: -36.32%, 95 % CI: -40.75 to -31.90) and elevated the level of high-density lipoprotein cholesterol (mean change: 6.29 %, 95 % CI: 5.12 to 7.46) and apolipoprotein A1(mean change: 4.86%, 95 % CI: 3.77 to 5.95). Therapy with and without PCSK9 antibodies did not differ in rate of adverse events (pooled rate: 50.86 % vs. 48.63%; RR: 1.03; 95 % CI: 0.92 to 1.15; P = 0.64; heterogeneity P = 0.13; I2= 40%) or serious adverse events (pooled rate: 7.14% vs. 6.74%; RR: 1.05; 95 % CI: 0.70 to 1.58; P = 0.80; heterogeneity P = 0.69; I2= 0%). PCSK9 antibody may be an effective and safe treatment for FH.

Inhibitory effects of short hairpin RNA against caspase-8 on apoptosis of murine hepatoma Hepa1-6 cells.

Caspase-8 plays an important role in death-receptor-mediated apoptosis of hepatocytes. We constructed short hairpin RNAs (shRNAs) against caspase-8 and investigated the effects of caspase-8 targeting shRNAs on apoptosis of Hepa1-6 cells induced by TNF-alpha. Oligonucleotides coding for four shRNAs against caspase-8 were cloned into mammalian expression vector Pgenesil-1 containing U6 promoter, which were then introduced into Hepa1-6 cells using liposome-mediated transfection. Effects of caspase-8-shRNAs on apoptosis of Hepa1-6 cells induced by TNF-alpha were detected by PI apoptosis detection kit. Effects of caspase-8-shRNAs on caspase-8 mRNA expression in apoptosis Hepa1-6 cells induced by TNF-alpha were detected by real-time fluorescent RT-PCR. Of the four caspase-8-shRNAs, Pgenesil-caspase-8-1 and Pgenesil-caspase-8-2 were successfully constructed. The apoptosis of Hepa1-6 cells induced by TNF-alpha was significantly inhibited by either Pgenesil-caspase-8-1 or Pgenesil-caspase-8-2 (p < 0.05). Caspase-8 mRNA expression levels in apoptosis Hepa1-6 cells induced by TNF-alpha were significantly decreased by either Pgenesil-caspase-8-1 or Pgenesil-caspase-8-2 (p < 0.05). This study suggested that shRNAs against caspase-8 could effectively inhibit apoptosis of Hepa1-6 cells induced by TNF-alpha by suppressing caspase-8 mRNA expression.